The Novel Dual PI3K/mTOR Inhibitor NVP-BGT226 Displays Cytotoxic Activity in Both Normoxic and Hypoxic Hepatocarcinoma Cells

McCubrey, James A.2022-02-042022-02-042015-07-101949-2553http://hdl.handle.net/10342/9633en-USHepatocellular carcinoma (HCC)NVP-BGT226PI3K/Akt signalingThe Novel Dual PI3K/mTOR Inhibitor NVP-BGT226 Displays Cytotoxic Activity in Both Normoxic and Hypoxic Hepatocarcinoma CellsArticle10.18632/oncotarget.3940